Correlation of serum adiponectin with thyroid profile among metabolic syndrome patients with and without hypothyroidism.

Authors: D S, A P, Lakshmanna N, Ekambaram G, Ganesh V.

DOI: 10.6026/973206300212971

Abstract Summary

Study reveals serum adiponectin levels are significantly decreased in metabolic syndrome patients, whether or not they have hypothyroidism. This biomarker shows negative correlation with blood sugar, lipids, and TSH, suggesting it could serve as a valuable diagnostic tool for identifying patients at risk for type 2 diabetes and cardiovascular disease complications.

Why Brain? 🧠

Low adiponectin in metabolic syndrome patients—with or without hypothyroidism—signals higher T2DM and CVD risk, positioning it as a valuable diagnostic biomarker.

Study Limitations:

Cross-sectional study design

License: cc by.

The image is AI-generated for illustrative purposes only. Courtesy of Midjourney.